Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Sarah S., Smith, Becky A., Akinboyo, Ibukunoluwa C., Seidelman, Jessica, Wolfe, Cameron, Kirk, Allan B., Martin, Gavin, Denny, Thomas, Lobaugh, Bruce, Rehder, Catherine, Cardona, Diana, Lee, Mark J., Polage, Christopher R., Datto, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450245/
https://www.ncbi.nlm.nih.gov/pubmed/32741409
http://dx.doi.org/10.1017/ice.2020.398
Descripción
Sumario:We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

Ejemplares similares